Expert FDA advisory across every regulated category — from first shipment to full lifecycle compliance.
Strategic advisory, specialized expertise, and end-to-end accountability across pharmaceuticals, APIs, cosmetics, OTC drugs, food, and dietary supplements. One point of contact. Your entire regulatory lifecycle.
Whether you're entering the U.S. market for the first time, managing ongoing compliance obligations, or a U.S. brand navigating a new regulatory landscape — Axentra provides expert guidance at every stage.
Pharmaceutical, API, cosmetic, food, or supplement manufacturers navigating FDA requirements for the first time.
Foreign manufacturers with existing U.S. market presence who need ongoing compliance management and strategic regulatory advisory.
U.S.-based brands keeping pace with MoCRA, OTC monograph reforms, and evolving FDA enforcement priorities.
From U.S. Agent representation to MoCRA registration to pharmaceutical dossier authoring — one firm, every stage.
Every structural decision at Axentra protects the quality of your engagement — from how we assign consultants to how quickly we respond when it matters most.
One consultant. One relationship. From your first inquiry through registration, listing, label review, and beyond — the same expert manages your account throughout. No re-explaining your situation. No dropped context between handoffs.
Our consultants never manage more than three active engagements at once. This is a firm policy — not a preference. It is how we guarantee your project receives focused, unhurried attention rather than a fraction of an overloaded schedule.
Every inquiry is answered by the regulatory expert assigned to your account — not screened by a coordinator, not routed through an automated portal. We commit to a substantive expert response within 24 hours of any issue raised during an active engagement.
Deep domain knowledge across pharmaceuticals, APIs, cosmetics, OTC drugs, and supplements — not a generalist registration portal. We advise on regulatory strategy, not just process paperwork. Our consultants know the CFR, not just the forms.
The difference is structural, not cosmetic. How a firm is organized determines what clients actually experience — and what their regulatory outcomes look like.
The Modernization of Cosmetics Regulation Act introduced the most sweeping changes to U.S. cosmetics law in over 85 years. Facility registration and product listing deadlines have passed. Brands that remain unregistered face FDA enforcement action, import alerts, and disruption to U.S. sales.
A clear, three-step engagement. No discovery calls that lead nowhere. No vague proposals. Just expert assessment and a transparent fixed-fee roadmap.
Tell us your product category, country of origin, and compliance need using either form on this page. Under two minutes. No commitment required.
Under 2 minutesA senior FDA regulatory expert reviews your situation and responds within 24 hours with a substantive assessment of your obligations, risks, and recommended pathway — at no charge.
Within 24 hoursYou receive a transparent, fixed-fee proposal and a complete regulatory roadmap. Scope and cost agreed upfront — no hourly billing, no surprises. We proceed only when you're ready.
Transparent pricingExpert response within 24 hours · No obligation
